Overview

Lab School Day Study for CONCERTA of Older Children With ADHD

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine if the study medication, CONCERTA (methylphenidate HCl), is safe and effective in improving academic performance and behavior in children with attention deficit hyperactivity disorder (ADHD), when compared to placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Ortho-McNeil Janssen Scientific Affairs, LLC
Treatments:
Methylphenidate